Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 4, 2026

The Doctor Who Sees the X-Ray Before the Patient Feels the Pain: Jim Rickards Says the AI Tumor Is Already There — Most People Just Haven't Been Told Yet

View original at globenewswire.com
The Doctor Who Sees the X-Ray Before the Patient Feels the Pain: Jim Rickards Says the AI Tumor Is Already There — Most People Just Haven't Been Told Yet Washington, D.C., April 04, 2026 (GLOBE NEWSWIRE) -- There is a specific kind of dread that comes from learning a threat was already present before any symptoms appea…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The collapse has already started behind the scenes

    60% confidence
  • In January 2020, issued CONTAGION note predicting a pandemic-driven market panic three weeks before stocks suffered the fastest crash in history

    60% confidence
  • The CFO of the AI company identified as central failure point has implied publicly that a government bailout may be required

    60% confidence
  • The evidence of a coming AI market collapse is already present in the balance sheets, financing arrangements, insider behavior, and structural fragilities of the AI sector

    60% confidence
  • This is not a prediction, it is an observation - describing what is already happening, visible to anyone with access to the right data points

    60% confidence
  • The company at the center of the AI financial system is showing the same distress signals Lehman showed weeks before its failure

    60% confidence
  • In 2008, warned that financial catastrophe was imminent three weeks before Lehman Brothers collapsed

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com
The Doctor Who Sees the X-Ray Before the Patient Feels the Pain: Jim Rickards Says the AI Tumor Is Already There — Most People Just Haven't Been Told Yet — Source | Via News | ViaNews Market